CHEN Rong. Interpretation on the 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 514-519. DOI: 10.12290/xhyxzz.2023-0190
Citation: CHEN Rong. Interpretation on the 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 514-519. DOI: 10.12290/xhyxzz.2023-0190

Interpretation on the 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines

Funds: 

National High Level Hospital Clinical Research Funding 2022-PUMCH-B-123

More Information
  • Author Bio:

    CHEN Rong, E-mail: chenrongpumch@163.com

  • Received Date: April 11, 2023
  • Accepted Date: April 23, 2023
  • Available Online: April 26, 2023
  • Issue Publish Date: May 29, 2023
  • The essence of menopause is ovarian failure, which has a significant impact on women's health. The goal of menopausal management is to relieve menopause-related symptoms, and hopefully, prevent chronic diseases in old age. Based on comprehensive lifestyle management, various health care measures including menopausal hormone therapy have been carried out under the guidance of professional medical practitioners so as to improve and enhance the quality of life of middle-aged and elderly women. The 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines was officially published in January 2023, and this article interprets the core points of the guidelines, especially the main updates, in order to better guide clinical practice.
  • [1]
    Bai R, Liu Y, Zhang L, et al. Projections of future life expectancy in China up to 2035: a modelling study[J]. Lance Public Health, 2023: S2468-2667(22)00338-3.
    [2]
    中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南2023版[J]. 中华妇产科杂志, 2023, 58: 4-21. https://www.cnki.com.cn/Article/CJFDTOTAL-XHYX201806007.htm
    [3]
    中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南(2018)[J]. 协和医学杂志, 2018, 9: 512-525. DOI: 10.3969/j.issn.1674-9081.2018.06.007
    [4]
    Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual articipant meta-analysis of the worldwide epidemiological evidence[J]. Lancet, 2019, 394: 1159-1168. DOI: 10.1016/S0140-6736(19)31709-X
    [5]
    Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases[J]. BMJ, 2020, 371: m3873. http://www.xueshufan.com/publication/3097702496
    [6]
    Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of Menopausal Hormone Therapy with Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials[J]. JAMA, 2020, 324: 369-380. DOI: 10.1001/jama.2020.9482
    [7]
    The 2022 hormone therapy position statement of The North American Menopause Society[J]. Menopause, 2022, 29: 767-794.
    [8]
    Academic Committee of the Korean Society of Menopause, Lee SR, Cho MK, et al. The 2020 Menopausal Hormone Therapy Guidelines[J]. J Menopausal Med, 2020, 26: 69-98. DOI: 10.6118/jmm.20000
    [9]
    Harlow SD, Gass M, Hall JE, et al. STRAW+10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging[J]. Menopause, 2012, 19: 387-395. DOI: 10.1097/gme.0b013e31824d8f40
    [10]
    Li J, Luo M, Tang R, et al. Vasomotor symptoms in aging Chinese women: findings from a prospective cohort study[J]. Climacteric, 2020, 23: 46-52. DOI: 10.1080/13697137.2019.1628734
    [11]
    Saccardi C, Spagnol G, Bonaldo G, et al. New Light on Endometrial Thickness as a Risk Factor of Cancer: What Do Clinicians Need to Know?[J]. Cancer Manag Res, 2022, 14: 1331-1340. DOI: 10.2147/CMAR.S294074
    [12]
    中华医学会妇产科学分会绝经学组. 围绝经期异常子宫出血诊断和治疗专家共识[J]. 中华妇产科杂志, 2018, 53: 396-401 DOI: 10.3760/cma.j.issn.0529-567x.2018.06.007
    [13]
    绝经生殖泌尿综合征临床诊疗专家共识专家组. 绝经生殖泌尿综合征临床诊疗专家共识[J]. 中华妇产科杂志, 2020, 55: 659-666.
    [14]
    中华医学会计划生育学分会. 40岁及以上女性避孕指导专家共识[J]. 中华妇产科杂志, 2020, 55: 239-245.
  • Related Articles

    [1]TIAN Zhuang, ZHANG Shuyang. Interpretation on Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 801-806. DOI: 10.12290/xhyxzz.2024-0292
    [2]TIAN Xinping, ZHAO Jiuliang, LI Mengtao, SONG Yijun, LIU Juntao, ZENG Xiaofeng. Interpretation on the 2022 Chinese Guideline for the Management of Pregnancy and Reproduction in Patients with Systemic Lupus Erythematous[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 504-513. DOI: 10.12290/xhyxzz.2023-0119
    [3]LIANG Yun, WU Wenming, NIE Yongzhan, CHEN Jie. Interpretation on the Chinese Guideline for Diagnosis and Treatment of Neuroendocrine Neoplasms from The China Anti-Cancer Association(2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 94-100. DOI: 10.12290/xhyxzz.2022-0607
    [4]WU Juelun, SHEN Le. Evaluation, Preparation, Decision, and Oxygenation: Interpretation on 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 421-426. DOI: 10.12290/xhyxzz.2022-0075
    [5]WANG Lin, SONG Hongmei. Interpretation on Chinese Guidelines for the Diagnosis and Treatment of Childhood-onset Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 412-420. DOI: 10.12290/xhyxzz.2022-0018
    [6]Ying XU, Ya-li XU, Zhe WANG, Yan LIN, Chang-jun WANG, Qiang SUN. Menopausal Hormone Therapy Increases the Risk of Breast Cancer:Interpretation on an Article Published in the Lancet Sep. 2019[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(5): 621-625. DOI: 10.3969/j.issn.1674-9081.2020.05.020
    [7]Yun WANG, Ze-hao WU, Yu-guang HUANG. Standardization and Normalization: Interpretation on Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery after Surgery Society Recommendations[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 575-581. DOI: 10.3969/j.issn.1674-9081.2019.06.005
    [8]Zi-jia LIU, Hui-zhen HUANG, Yu-guang HUANG. From Enhanced Recovery after Surgery to Day-case Surgery: Interpretation on Guidelines for Day-case Surgery 2019: Guidelines from the Association of Anaesthetists and the British Association of Day Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 570-574. DOI: 10.3969/j.issn.1674-9081.2019.06.004
    [9]Xiao-dong TIAN, Yin-mo YANG. Concept Renewal Leads to Behavior Progress: Interpretation on the Surgical Part of Consensus on ERAS and Guidelines for Pathway Management in China (2018)[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(6): 485-489. DOI: 10.3969/j.issn.1674-9081.2018.06.002
    [10]Tian-long WANG, Yu-guang HUANG. Campaigning for the Transformation from Anesthesiology to Perioperative Medicine: Interpretation on the Anesthesia Part of Consensus on ERAS and Guidelines for the Pathway Management in China (2018)[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(6): 481-484. DOI: 10.3969/j.issn.1674-9081.2018.06.001
  • Cited by

    Periodical cited type(5)

    1. 姜文鑫,刘鹏. 程序性细胞死亡受体1单抗联合治疗复发难治霍奇金淋巴瘤的研究进展. 中华医学杂志. 2024(07): 552-558 .
    2. 刘斌,郭述良. 晚期非小细胞肺癌免疫检查点抑制剂治疗的研究进展. 中国癌症防治杂志. 2024(02): 243-248 .
    3. 刘彦君,张颖. 免疫检查点抑制剂治疗卵巢癌的研究进展. 中国临床医生杂志. 2024(08): 883-887 .
    4. 叶汉挹,吕舜,黎迎,董政起. 植物来源miR261、miR354及miR194调控多种肿瘤细胞增殖并靶向HDAC2或CTLA-4. 生命科学研究. 2024(06): 483-492 .
    5. 卫浩,杨树军,王科,孙圣坤. 共刺激信号通路在异种移植中的作用研究进展. 器官移植. 2023(06): 810-816 .

    Other cited types(1)

Catalog

    Article Metrics

    Article views (4004) PDF downloads (3276) Cited by(6)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close